| TA154 |
Hepatitis B - telbivudine (TA154) |
|
-
-
Telbivudine for the treatment of chronic hepatitis B
Telbivudine is not recommended for people with chronic hepatitis B. Healthcare professionals should not stop prescribing telbivudine for people who were already taking it when the guidance was issued.These patients should be able to carry on taking telbivudine until they and their healthcareprofessionals decide that it is the right time to stop treatment.
We will consult on our review plans for this guidance in February 2009.
-
Other information
How this guidance was produced
Background information
This page was last updated: 07 October 2011
-
Guidance formats
-
Implementation tools and resources
See this guidance in practice
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guidance
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
Full Guidance
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.
